scispace - formally typeset
N

Nicola Mascolo

Researcher at University of Naples Federico II

Publications -  160
Citations -  8472

Nicola Mascolo is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Cannabinoid receptor & Cannabinoid. The author has an hindex of 48, co-authored 157 publications receiving 7813 citations. Previous affiliations of Nicola Mascolo include University of Salerno & Yale University.

Papers
More filters
Journal ArticleDOI

Flavonoids : old and new aspects of a class of natural therapeutic drugs

TL;DR: This review summarizes available data on these beneficial effects of flavonoids and suggests that the compounds may possess significant antihepatotoxic, antiallergic, anti-inflammatory, antiosteoporotic and even antitumor activities.
Journal ArticleDOI

Ethnopharmacologic investigation of ginger (Zingiber officinale).

TL;DR: An ethanolic extract of the rhizomes of Zingiber officinale was investigated for anti-inflammatory, analgesic, antipyretic, antimicrobial and hypoglycaemic activities in rats and rabbits and was ineffective in suppressing the writhing induced by intraperitoneal acetic acid.
Journal ArticleDOI

Inhibition of intestinal motility and secretion by flavonoids in mice and rats: structure-activity relationships.

TL;DR: Yohimbine antagonized the inhibitory effect of flavonols (12·5–50 mg kg−1) on intraluminal accumulation of fluid and diarrhoea induced by castor oil and verapamil potentiated the flavonol effect.
Journal ArticleDOI

Cannabinoid CB1‐receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation

TL;DR: It is concluded that inflammation of the gut increases the potency of cannabinoid agonists possibly by ‘up‐regulating’ CB1 receptor expression; in addition, endocannabinoids, whose turnover is increased in inflamed gut, might tonically inhibit intestinal motility.
Journal ArticleDOI

Endocannabinoids as physiological regulators of colonic propulsion in mice

TL;DR: Endocannabinoids acting on myenteric CB1 receptors tonically inhibit colonic propulsion in mice, and high amounts of 2-arachidonylglycerol and particularly anandamide were found in the colon, together with a high activity of an andamide amidohydrolase.